Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

Cytological analysis of small branch-duct intraductal papillary mucinous neoplasms provides a more accurate risk assessment of malignancy than symptoms.

Ono J, Yaeger KA, Genevay M, Mino-Kenudson M, Brugge WR, Pitman MB.

Cytojournal. 2011;8:21. doi: 10.4103/1742-6413.90084. Epub 2011 Nov 21.

PMID:
22145009
[PubMed]
Free PMC Article
2.

Cytology adds value to imaging studies for risk assessment of malignancy in pancreatic mucinous cysts.

Genevay M, Mino-Kenudson M, Yaeger K, Konstantinidis IT, Ferrone CR, Thayer S, Castillo CF, Sahani D, Bounds B, Forcione D, Brugge WR, Pitman MB.

Ann Surg. 2011 Dec;254(6):977-83. doi: 10.1097/SLA.0b013e3182383118.

PMID:
22041510
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasm.

Tang RS, Weinberg B, Dawson DW, Reber H, Hines OJ, Tomlinson JS, Chaudhari V, Raman S, Farrell JJ.

Clin Gastroenterol Hepatol. 2008 Jul;6(7):815-9; quiz 719. doi: 10.1016/j.cgh.2008.04.005.

PMID:
18602036
[PubMed - indexed for MEDLINE]
4.

Single-institution validation of the international consensus guidelines for treatment of branch duct intraductal papillary mucinous neoplasms of the pancreas.

Nagai K, Doi R, Ito T, Kida A, Koizumi M, Masui T, Kawaguchi Y, Ogawa K, Uemoto S.

J Hepatobiliary Pancreat Surg. 2009;16(3):353-8. doi: 10.1007/s00534-009-0068-8. Epub 2009 Mar 12.

PMID:
19280108
[PubMed - indexed for MEDLINE]
5.

Cytological and cyst fluid analysis of small (< or =3 cm) branch duct intraductal papillary mucinous neoplasms adds value to patient management decisions.

Pitman MB, Michaels PJ, Deshpande V, Brugge WR, Bounds BC.

Pancreatology. 2008;8(3):277-84. doi: 10.1159/000134276. Epub 2008 May 22.

PMID:
18497541
[PubMed - indexed for MEDLINE]
6.

Cyst features and risk of malignancy in intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis.

Anand N, Sampath K, Wu BU.

Clin Gastroenterol Hepatol. 2013 Aug;11(8):913-21; quiz e59-60. doi: 10.1016/j.cgh.2013.02.010. Epub 2013 Feb 13. Review.

PMID:
23416279
[PubMed - indexed for MEDLINE]
7.

Endoscopic ultrasonographic findings predict the risk of carcinoma in branch duct intraductal papillary mucinous neoplasms of the pancreas.

Kobayashi N, Sugimori K, Shimamura T, Hosono K, Watanabe S, Kato S, Ueda M, Endo I, Inayama Y, Maeda S, Nakajima A, Kubota K.

Pancreatology. 2012 Mar-Apr;12(2):141-5. doi: 10.1016/j.pan.2011.12.008. Epub 2012 Jan 14.

PMID:
22487524
[PubMed - indexed for MEDLINE]
8.

The carcinoembryonic antigen level in pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas.

Hirono S, Tani M, Kawai M, Okada K, Miyazawa M, Shimizu A, Kitahata Y, Yamaue H.

Ann Surg. 2012 Mar;255(3):517-22. doi: 10.1097/SLA.0b013e3182444231.

PMID:
22301608
[PubMed - indexed for MEDLINE]
9.

Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules.

Sadakari Y, Ienaga J, Kobayashi K, Miyasaka Y, Takahata S, Nakamura M, Mizumoto K, Tanaka M.

Pancreas. 2010 Mar;39(2):232-6. doi: 10.1097/MPA.0b013e3181bab60e.

PMID:
19752768
[PubMed - indexed for MEDLINE]
10.

Cytological criteria of high-grade epithelial atypia in the cyst fluid of pancreatic intraductal papillary mucinous neoplasms.

Pitman MB, Centeno BA, Daglilar ES, Brugge WR, Mino-Kenudson M.

Cancer Cytopathol. 2014 Jan;122(1):40-7. doi: 10.1002/cncy.21344. Epub 2013 Aug 12.

PMID:
23939829
[PubMed - indexed for MEDLINE]
11.

An increase in the number of predictive factors augments the likelihood of malignancy in branch duct intraductal papillary mucinous neoplasm of the pancreas.

Ohtsuka T, Kono H, Nagayoshi Y, Mori Y, Tsutsumi K, Sadakari Y, Takahata S, Morimatsu K, Aishima S, Igarashi H, Ito T, Ishigami K, Nakamura M, Mizumoto K, Tanaka M.

Surgery. 2012 Jan;151(1):76-83. doi: 10.1016/j.surg.2011.07.009. Epub 2011 Aug 27.

PMID:
21875733
[PubMed - indexed for MEDLINE]
12.

Pancreatic-duct-lavage cytology in candidates for surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas: should the International Consensus Guidelines be revised?

Sai JK, Suyama M, Kubokawa Y, Watanabe S, Maehara T.

Gastrointest Endosc. 2009 Mar;69(3 Pt 1):434-40. doi: 10.1016/j.gie.2008.04.050. Epub 2008 Aug 5.

PMID:
18684453
[PubMed - indexed for MEDLINE]
13.

Comparison of International Consensus Guidelines versus 18-FDG PET in detecting malignancy of intraductal papillary mucinous neoplasms of the pancreas.

Pedrazzoli S, Sperti C, Pasquali C, Bissoli S, Chierichetti F.

Ann Surg. 2011 Dec;254(6):971-6. doi: 10.1097/SLA.0b013e3182383137.

PMID:
22076067
[PubMed - indexed for MEDLINE]
14.

Endoscopic ultrasound-guided fine-needle aspiration cytology in the diagnosis of intraductal papillary mucinous neoplasms of the pancreas. A study of 8 cases.

Salla C, Chatzipantelis P, Konstantinou P, Karoumpalis I, Sakellariou S, Pantazopoulou A, Manika Z.

JOP. 2007 Nov 9;8(6):715-24.

PMID:
17993724
[PubMed - indexed for MEDLINE]
Free Article
15.

Predictors of malignancy in branch duct intraductal papillary mucinous neoplasm of the pancreas.

Kawada N, Uehara H, Nagata S, Tsuchishima M, Tsutsumi M, Tomita Y.

JOP. 2014 Sep 28;15(5):459-64. doi: 10.6092/1590-8577/2805.

PMID:
25262713
[PubMed - in process]
Free Article
16.

Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification.

Serikawa M, Sasaki T, Fujimoto Y, Kuwahara K, Chayama K.

J Clin Gastroenterol. 2006 Oct;40(9):856-62.

PMID:
17016145
[PubMed - indexed for MEDLINE]
17.

Intraductal papillary mucinous neoplasms of the pancreas: performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy.

Maire F, Voitot H, Aubert A, Palazzo L, O'Toole D, Couvelard A, Levy P, Vidaud M, Sauvanet A, Ruszniewski P, Hammel P.

Am J Gastroenterol. 2008 Nov;103(11):2871-7. doi: 10.1111/j.1572-0241.2008.02114.x. Epub 2008 Sep 4.

PMID:
18775021
[PubMed - indexed for MEDLINE]
18.

Additional value of FDG PET/CT to contrast-enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the pancreas with mural nodules.

Takanami K, Hiraide T, Tsuda M, Nakamura Y, Kaneta T, Takase K, Fukuda H, Takahashi S.

Ann Nucl Med. 2011 Aug;25(7):501-10. doi: 10.1007/s12149-011-0494-y. Epub 2011 May 3.

PMID:
21537945
[PubMed - indexed for MEDLINE]
19.

Small-sized, flat-type invasive branch duct intraductal papillary mucinous neoplasm: a case report.

Shindo K, Ueda J, Aishima S, Aso A, Ohtsuka T, Takahata S, Ishigami K, Oda Y, Tanaka M.

Case Rep Gastroenterol. 2013 Oct 9;7(3):449-54. doi: 10.1159/000355939. eCollection 2013.

PMID:
24403884
[PubMed]
Free PMC Article
20.

Prospective analysis of atypical epithelial cells as a high-risk cytologic feature for malignancy in pancreatic cysts.

Pitman MB, Yaeger KA, Brugge WR, Mino-Kenudson M.

Cancer Cytopathol. 2013 Jan;121(1):29-36. doi: 10.1002/cncy.21242. Epub 2012 Nov 6.

PMID:
23132817
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk